Board Decisions

GF/B39/EDP17

Approved by the Board on: 05 November 2018

Key Performance Indicator 12b: Availability of Affordable Health Technologies: Affordability

  1. Based on the recommendation of the Audit and Finance Committee, the Board approves the 2019 performance target of USD 115 million for Key Performance Indicator 12b as presented in GF/B39/ER14A.

Budgetary Implications

This decision has no budgetary implications.

}